<b>Conclusions</b>: In this study, a five-gene signature derived from the TP53 signaling pathway was developed, and the model was shown to effectively predict the prognoses of NSCLC patients undergoing radiotherapy. Here, TP53 is linked to non-small cell lung carcinoma.